Huaping Yang
Impact in
-
- Lung Cancer Treatments and Mutations
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Lung Cancer Diagnosis and Treatment
-
- MicroRNA in disease regulation
Papers in
-
- Lung Cancer Treatments and Mutations 8
- Lung Cancer Diagnosis and Treatment 6
-
- MicroRNA in disease regulation 4
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Chengping Hu (17 shared papers)Liming Cao (16 shared papers)Pengbo Deng (15 shared papers)Qihua Gu (7 shared papers)Jian An (7 shared papers)Yuanyuan Li (6 shared papers)Zeng Xiong (4 shared papers)Jingjing Li (2 shared papers)
- Journals
- Lung Cancer (2 papers)International Journal of Oncology (2 papers)Frontiers in Oncology (2 papers)Annals of Translational Medicine (2 papers)Chinese Journal of Natural Medicines (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Huaping Yang
38 papers receiving 753 citations
Huaping Yang's Hit Papers
Peers
Comparison fields: 5 of 69
- Pulmonary and Respiratory Medicine 269
- Cancer Research 106
- Oncology 156
- Pathology and Forensic Medicine 76
- Drug Discovery 1
Countries citing papers authored by Huaping Yang
This map shows the geographic impact of Huaping Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huaping Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huaping Yang more than expected).
Fields of papers citing papers by Huaping Yang
This network shows the impact of papers produced by Huaping Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huaping Yang. The network helps show where Huaping Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Huaping Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial Hit paper breakdown → | 2024 | 89 |
| 2 | 2015 | 76 | |
| 3 | 2018 | 72 | |
| 4 | 2016 | 41 | |
| 5 | 2014 | 30 | |
| 6 | 2013 | 29 | |
| 7 | 2012 | 28 | |
| 8 | 2012 | 28 | |
| 9 | 2012 | 24 | |
| 10 | 2013 | 23 | |
| 11 | 2017 | 22 | |
| 12 | 2019 | 22 | |
| 13 | 2022 | 22 | |
| 14 | 2014 | 21 | |
| 15 | 2014 | 21 | |
| 16 | 2021 | 20 | |
| 17 | 2023 | 20 | |
| 18 | 2019 | 18 | |
| 19 | 2022 | 18 | |
| 20 | 2014 | 16 |
About Huaping Yang
Huaping Yang is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Pathology and Forensic Medicine and Molecular Biology, having authored 39 papers that have together received 769 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Diagnosis and Treatment (6 papers), Lung Cancer Research Studies (5 papers), MicroRNA in disease regulation (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Tea Polyphenols and Effects (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (269 citations), Cancer Research (106 citations), Oncology (156 citations), Pathology and Forensic Medicine (76 citations) and Drug Discovery (1 citation). Huaping Yang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Chengping Hu, Liming Cao, Pengbo Deng, Qihua Gu, Jian An, Yuanyuan Li, Zeng Xiong, Jingjing Li, Wen Zhong and Jingjing Qu. Their work appears in journals such as Lung Cancer, International Journal of Oncology, Frontiers in Oncology, Annals of Translational Medicine and Chinese Journal of Natural Medicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.